Business Description
Biolase Inc
NAICS : 339114
SIC : 5047
ISIN : US0909112072
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 8.03 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -12.66 | |||||
Beneish M-Score | -3.43 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -65.7 | |||||
3-Year EBITDA Growth Rate | 72.4 | |||||
3-Year EPS without NRI Growth Rate | 72.5 | |||||
3-Year FCF Growth Rate | 71.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.38 | |||||
9-Day RSI | 57.34 | |||||
14-Day RSI | 49.37 | |||||
6-1 Month Momentum % | -95.06 | |||||
12-1 Month Momentum % | -99.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 162.58 | |||||
Days Sales Outstanding | 39.48 | |||||
Days Payable | 74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -343.8 | |||||
Shareholder Yield % | -167.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.02 | |||||
Operating Margin % | -36.48 | |||||
Net Margin % | -41.97 | |||||
FCF Margin % | -31.41 | |||||
ROE % | -365.45 | |||||
ROA % | -53.28 | |||||
ROIC % | -93.17 | |||||
ROC (Joel Greenblatt) % | -141.83 | |||||
ROCE % | -92.14 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.96 | |||||
EV-to-EBITDA | -1.13 | |||||
EV-to-Forward-EBITDA | -3.09 | |||||
EV-to-Revenue | 0.35 | |||||
EV-to-Forward-Revenue | 0.31 | |||||
EV-to-FCF | -1.13 | |||||
Earnings Yield (Greenblatt) % | -104.17 | |||||
FCF Yield % | -252.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biolase Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 45.565 | ||
EPS (TTM) (€) | -34.689 | ||
Beta | 1.78 | ||
Volatility % | 92.89 | ||
14-Day RSI | 49.37 | ||
14-Day ATR (€) | 0.035304 | ||
20-Day SMA (€) | 0.106175 | ||
12-1 Month Momentum % | -99.74 | ||
52-Week Range (€) | 0.0475 - 37.2 | ||
Shares Outstanding (Mil) | 32.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biolase Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biolase Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biolase Inc Frequently Asked Questions
What is Biolase Inc(FRA:BTH0)'s stock price today?
When is next earnings date of Biolase Inc(FRA:BTH0)?
Does Biolase Inc(FRA:BTH0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |